QAACX
Price
$55.87
Change
-$0.33 (-0.59%)
Updated
Jul 13 closing price
Net Assets
3.82B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

QAACX vs VFFSX

QAACX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
QAACX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QAACX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. QAACX (3.82B). VFFSX pays higher dividends than QAACX: VFFSX (1.08) vs QAACX (0.00). QAACX was incepted earlier than VFFSX: QAACX (23 years) vs VFFSX (10 years). QAACX (1.17) is less costly to investors than VFFSX (0.01). QAACX is a more actively managed with annual turnover of: 62.00 vs. VFFSX (2.00). QAACX has a lower initial minimum investment than VFFSX: QAACX (1500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. QAACX (12.92). VFFSX return over 5 years is better than : 73.48 vs. QAACX (34.64).
QAACXVFFSXQAACX / VFFSX
Total Expense Ratio1.050.0110,500%
Annual Report Gross Expense Ratio1.170.0111,700%
Fund Existence23 years10 years-
Gain YTD8.97810.68584%
Front Load6%N/A-
Min. Initial Investment150050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.82B1.67T0%
Annual Yield % from dividends0.001.080%
Returns for 1 year12.9221.0761%
Returns for 3 years62.1268.4591%
Returns for 5 years34.6473.4847%
Returns for 10 years169.28251.2167%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6